Kenneth C Cundy Insider Trading $XNPT XENOPORT INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Kenneth C Cundy.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Kenneth C Cundy. Kenneth C Cundy is SVP, Preclinical Development in XENOPORT INC ($XNPT) and Chief Scientific Officer in CohBar, Inc. ($COB.U:TSXV).

Kenneth C Cundy in XENOPORT INC

Trading Symbol: XNPT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kenneth C Cundy: SVP, Preclinical Development
Holdings: 43,851 shares
Latest Transaction: Mar 14 2012

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Kenneth C Cundy in XENOPORT INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, COBU, XNPT

Page:   1 2 3 4 5 ... 5 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 14 2012XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseM0.0010,000020,000
Mar 14 2012XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Payment of ExerciseF3.933,66814,41543,85147.5 K to 43.9 K (-7.72 %)
Mar 14 2012XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...BuyM0.0010,000047,51937.5 K to 47.5 K (+26.65 %)
Feb 01 2012XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseM0.001,25001,250
Feb 01 2012XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseM0.0062500
Feb 01 2012XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Payment of ExerciseF4.165232,17637,51938 K to 37.5 K (-1.37 %)
Feb 01 2012XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...BuyM0.001,250038,04236.8 K to 38 K (+3.40 %)
Feb 01 2012XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Payment of ExerciseF4.162611,08636,79237.1 K to 36.8 K (-0.70 %)
Feb 01 2012XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...BuyM0.00625037,05336.4 K to 37.1 K (+1.72 %)
Jan 17 2012XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseA4.3430,000130,20030,000
Jan 17 2012XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseA0.0030,000030,000
Jan 17 2012XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseM0.006,250018,750
Jan 17 2012XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseM0.001,25002,500
Jan 17 2012XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Payment of ExerciseF4.342,61711,35836,42839 K to 36.4 K (-6.70 %)
Jan 17 2012XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...BuyM0.006,250039,04532.8 K to 39 K (+19.06 %)
Jan 17 2012XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Payment of ExerciseF4.345232,27032,79533.3 K to 32.8 K (-1.57 %)
Jan 17 2012XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...BuyM0.001,250033,31832.1 K to 33.3 K (+3.90 %)
Jul 19 2011XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseM1.503,0004,5000
Jul 19 2011XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...BuyM1.503,0004,50032,06829.1 K to 32.1 K (+10.32 %)
Mar 16 2011XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseM0.0010,000030,000
Mar 16 2011XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Payment of ExerciseF7.203,71226,72625,86229.6 K to 25.9 K (-12.55 %)
Mar 16 2011XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...BuyM0.0010,000029,57419.6 K to 29.6 K (+51.09 %)
Feb 01 2011XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseM0.006250625
Feb 01 2011XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseM0.001,25002,500
Feb 01 2011XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Payment of ExerciseF7.882632,07219,57419.8 K to 19.6 K (-1.33 %)
Feb 01 2011XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...BuyM0.00625019,83719.2 K to 19.8 K (+3.25 %)
Feb 01 2011XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Payment of ExerciseF7.805264,10319,21219.7 K to 19.2 K (-2.66 %)
Feb 01 2011XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...BuyM0.001,250019,73818.5 K to 19.7 K (+6.76 %)
Jan 14 2011XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseA9.1650,000458,00050,000
Jan 14 2011XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseA0.0025,000025,000
Jan 14 2011XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseM0.001,25003,750
Jan 14 2011XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Payment of ExerciseF9.165264,81818,48819 K to 18.5 K (-2.77 %)
Jan 14 2011XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...BuyM0.001,250019,01417.8 K to 19 K (+7.04 %)
Mar 16 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseA0.0040,000040,000
Feb 26 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseM0.002,08500
Feb 26 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Payment of ExerciseF8.027455,97516,20116.9 K to 16.2 K (-4.40 %)
Feb 26 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...BuyM0.002,085016,94614.9 K to 16.9 K (+14.03 %)
Feb 04 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseM1.502,0003,0003,000
Feb 04 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS18.471001,84714,86115 K to 14.9 K (-0.67 %)
Feb 04 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS18.431001,84314,96115.1 K to 15 K (-0.66 %)
Feb 04 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS18.581001,85815,06115.2 K to 15.1 K (-0.66 %)
Feb 04 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS18.611001,86115,16115.3 K to 15.2 K (-0.66 %)
Feb 04 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS18.521001,85215,26115.4 K to 15.3 K (-0.65 %)
Feb 04 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS18.501001,85015,36115.5 K to 15.4 K (-0.65 %)
Feb 04 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS18.461001,84615,46115.6 K to 15.5 K (-0.64 %)
Feb 04 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS18.391001,83915,56115.7 K to 15.6 K (-0.64 %)
Feb 04 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS18.321001,83215,66115.8 K to 15.7 K (-0.63 %)
Feb 04 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS18.301001,83015,76115.9 K to 15.8 K (-0.63 %)
Feb 04 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS18.362003,67215,86116.1 K to 15.9 K (-1.25 %)
Feb 04 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS18.492003,69816,06116.3 K to 16.1 K (-1.23 %)
Feb 04 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS18.571001,85716,26116.4 K to 16.3 K (-0.61 %)
Feb 04 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS18.602003,72016,36116.6 K to 16.4 K (-1.21 %)
Feb 04 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS18.793056416,56116.6 K to 16.6 K (-0.18 %)
Feb 04 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS18.8023816,59116.6 K to 16.6 K (-0.01 %)
Feb 04 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS18.81681,27916,59316.7 K to 16.6 K (-0.41 %)
Feb 04 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS18.681001,86816,66116.8 K to 16.7 K (-0.60 %)
Feb 04 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS18.721001,87216,76116.9 K to 16.8 K (-0.59 %)
Feb 04 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...BuyM1.502,0003,00016,86114.9 K to 16.9 K (+13.46 %)
Feb 01 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseM0.0062501,250
Feb 01 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseM0.001,25003,750
Feb 01 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Payment of ExerciseF18.502694,97714,86115.1 K to 14.9 K (-1.78 %)
Feb 01 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...BuyM0.00625015,13014.5 K to 15.1 K (+4.31 %)
Feb 01 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Payment of ExerciseF18.555389,98014,50515 K to 14.5 K (-3.58 %)
Feb 01 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...BuyM0.001,250015,04313.8 K to 15 K (+9.06 %)
Jan 15 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseA20.0540,000802,00040,000
Jan 15 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseA0.005,00005,000
Jan 06 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseM1.502,0003,0005,000
Jan 06 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS19.201001,92013,79313.9 K to 13.8 K (-0.72 %)
Jan 06 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS19.171001,91713,89314 K to 13.9 K (-0.71 %)
Jan 06 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS19.521001,95213,99314.1 K to 14 K (-0.71 %)
Jan 06 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS19.361001,93614,09314.2 K to 14.1 K (-0.70 %)
Jan 06 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS19.263261614,19314.2 K to 14.2 K (-0.22 %)
Jan 06 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS19.252685,15914,22514.5 K to 14.2 K (-1.85 %)
Jan 06 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS19.282003,85614,49314.7 K to 14.5 K (-1.36 %)
Jan 06 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS19.231001,92314,69314.8 K to 14.7 K (-0.68 %)
Jan 06 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS19.222003,84414,79315 K to 14.8 K (-1.33 %)
Jan 06 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS19.271001,92714,99315.1 K to 15 K (-0.66 %)
Jan 06 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS19.242003,84815,09315.3 K to 15.1 K (-1.31 %)
Jan 06 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS19.081001,90815,29315.4 K to 15.3 K (-0.65 %)
Jan 06 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS19.14951,81815,39315.5 K to 15.4 K (-0.61 %)
Jan 06 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS19.1759615,48815.5 K to 15.5 K (-0.03 %)
Jan 06 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS18.841001,88415,49315.6 K to 15.5 K (-0.64 %)
Jan 06 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS18.781001,87815,59315.7 K to 15.6 K (-0.64 %)
Jan 06 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS18.751001,87515,69315.8 K to 15.7 K (-0.63 %)
Jan 06 2010XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...BuyM1.502,0003,00015,79313.8 K to 15.8 K (+14.50 %)
Oct 07 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseM1.801,0001,8009,805
Oct 07 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS22.001002,20013,79213.9 K to 13.8 K (-0.72 %)
Oct 07 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS22.0090019,80013,89214.8 K to 13.9 K (-6.08 %)
Oct 07 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...BuyM1.801,0001,80014,79213.8 K to 14.8 K (+7.25 %)
Sep 22 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseM1.801,0001,80010,805
Sep 22 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS24.781002,47813,79213.9 K to 13.8 K (-0.72 %)
Sep 22 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS24.951002,49513,89214 K to 13.9 K (-0.71 %)
Sep 22 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS24.151002,41513,99214.1 K to 14 K (-0.71 %)
Sep 22 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS24.291002,42914,09214.2 K to 14.1 K (-0.70 %)
Sep 22 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS24.581002,45814,19214.3 K to 14.2 K (-0.70 %)
Sep 22 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS24.771002,47714,29214.4 K to 14.3 K (-0.69 %)
Sep 22 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS24.851002,48514,39214.5 K to 14.4 K (-0.69 %)
Sep 22 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS25.001002,50014,49214.6 K to 14.5 K (-0.69 %)
Sep 22 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS24.472004,89414,59214.8 K to 14.6 K (-1.35 %)
Sep 22 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...BuyM1.801,0001,80014,79213.8 K to 14.8 K (+7.25 %)
Jul 02 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseM1.801,0001,80011,805
Jul 02 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS23.181002,31813,79213.9 K to 13.8 K (-0.72 %)
Jul 02 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS23.441002,34413,89214 K to 13.9 K (-0.71 %)
Jul 02 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS23.371002,33713,99214.1 K to 14 K (-0.71 %)
Jul 02 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS23.282004,65614,09214.3 K to 14.1 K (-1.40 %)
Jul 02 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS23.212004,64214,29214.5 K to 14.3 K (-1.38 %)
Jul 02 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS23.231002,32314,49214.6 K to 14.5 K (-0.69 %)
Jul 02 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS23.051002,30514,59214.7 K to 14.6 K (-0.68 %)
Jul 02 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS23.571002,35714,69214.8 K to 14.7 K (-0.68 %)
Jul 02 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...BuyM1.801,0001,80014,79213.8 K to 14.8 K (+7.25 %)
Jun 15 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseM1.801,0001,80012,805
Jun 15 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS22.001,00022,00013,79214.8 K to 13.8 K (-6.76 %)
Jun 15 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...BuyM1.801,0001,80014,79213.8 K to 14.8 K (+7.25 %)
Mar 26 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseM1.8054497913,805
Mar 26 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS22.0054411,96813,04013.6 K to 13 K (-4.00 %)
Mar 26 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...BuyM1.8054497913,58413 K to 13.6 K (+4.17 %)
Feb 19 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseM0.001,04202,086
Feb 19 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Payment of ExerciseF26.733729,94413,04013.4 K to 13 K (-2.77 %)
Feb 19 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...BuyM0.001,042013,41212.4 K to 13.4 K (+8.42 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.941002,69412,37012.5 K to 12.4 K (-0.80 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS27.011002,70112,47012.6 K to 12.5 K (-0.80 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.901002,69012,57012.7 K to 12.6 K (-0.79 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseM1.803,0005,40014,349
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.801002,68012,67012.8 K to 12.7 K (-0.78 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.931002,69312,77012.9 K to 12.8 K (-0.78 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.961002,69612,87013 K to 12.9 K (-0.77 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.871002,68712,97013.1 K to 13 K (-0.77 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.851002,68513,07013.2 K to 13.1 K (-0.76 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.942005,38813,17013.4 K to 13.2 K (-1.50 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS27.121002,71213,37013.5 K to 13.4 K (-0.74 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.951002,69513,47013.6 K to 13.5 K (-0.74 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.921002,69213,57013.7 K to 13.6 K (-0.73 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.831002,68313,67013.8 K to 13.7 K (-0.73 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.792005,35813,77014 K to 13.8 K (-1.43 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.89992,66213,97014.1 K to 14 K (-0.70 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.9112714,06914.1 K to 14.1 K (-0.01 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.811002,68114,07014.2 K to 14.1 K (-0.71 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.751002,67514,17014.3 K to 14.2 K (-0.70 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.621002,66214,27014.4 K to 14.3 K (-0.70 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.491002,64914,37014.5 K to 14.4 K (-0.69 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.721002,67214,47014.6 K to 14.5 K (-0.69 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.641002,66414,57014.7 K to 14.6 K (-0.68 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.261002,62614,67014.8 K to 14.7 K (-0.68 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS27.101002,71014,77014.9 K to 14.8 K (-0.67 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.971002,69714,87015 K to 14.9 K (-0.67 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.871002,68714,97015.1 K to 15 K (-0.66 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.561002,65615,07015.2 K to 15.1 K (-0.66 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.281002,62815,17015.3 K to 15.2 K (-0.65 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.672977315,27015.3 K to 15.3 K (-0.19 %)
Feb 03 2009XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS26.63711,89115,29915.4 K to 15.3 K (-0.46 %)

Page:   1 2 3 4 5 ... 5 next >